HYDROXYCHLOROQUINE DOES NOT INCREASE PSORIASIS IN PSORIATIC ARTHRITIS: TIME ON DRUG ANALYSIS BASED ON REAL LIFE DATA

被引:1
|
作者
Aydin, S. Z. [1 ]
Yilmazer, B. [1 ]
Bayindir, O. [1 ]
Aksu, K. [1 ]
Dalkilic, E. [1 ]
Oksuz, M. F. [1 ]
Tarhan, E. F. [1 ]
Can, M. [1 ]
Kucuksahin, O. [1 ]
Kimyon, G. [1 ]
Akyol, L. [1 ]
Onat, A. M. [1 ]
Kisacik, B. [1 ]
Erden, A. [1 ]
Omma, A. [1 ]
Bozkirli, E. D. Ersozlu [1 ]
Oziseler, C. [1 ]
Gonullu, E. [1 ]
Pehlevan, S. Masatlioglu [1 ]
Tufan, M. Aydin [1 ]
Solmaz, D. [1 ]
Cetin, G. Yildirim [1 ]
Kilic, L. [1 ]
Erten, S. [1 ]
Kasifoglu, T. [1 ]
Senel, S. [1 ]
Gunal, E. Kasapoglu [1 ]
Kabasakal, Y. [1 ]
Sayarlioglu, M. [1 ]
Kalyoncu, U. [1 ]
机构
[1] PsART Study Grp, Ankara, Turkey
关键词
D O I
10.1136/annrheumdis-2015-eular.5071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB0827
引用
收藏
页码:1177 / 1177
页数:1
相关论文
共 50 条
  • [1] Time on drug analysis based on real life data
    Schuelter, Eugen
    Kaiser, Rolf
    Zazzi, Maurizio
    Soennerborg, Anders
    Camacho, Ricardo
    Verheyen, Jens
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 182 - 182
  • [2] Time on drug analysis based on real life data
    Schuelter, E.
    Kaiser, R.
    Zazzi, M.
    Soennerborg, A.
    Camacho, R.
    Verheyen, J.
    [J]. ANTIVIRAL THERAPY, 2014, 19 : A133 - A133
  • [3] Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
    Dattola, Annunziata
    Cannizzaro, Maria Vittoria
    Mazzeo, Mauro
    Bianchi, Luca
    [J]. DERMATOLOGY AND THERAPY, 2017, 7 (04) : 485 - 492
  • [4] Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
    Annunziata Dattola
    Maria Vittoria Cannizzaro
    Mauro Mazzeo
    Luca Bianchi
    [J]. Dermatology and Therapy, 2017, 7 : 485 - 492
  • [5] Correction to: Certolizumab Pegol in the Treatment of Psoriasis and Psoriatic Arthritis: Preliminary Real-Life Data
    Annunziata Dattola
    Maria Vittoria Cannizzaro
    Mauro Mazzeo
    Luca Bianchi
    [J]. Dermatology and Therapy, 2018, 8 : 171 - 171
  • [6] Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD
    Smith, Malcolm D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (02)
  • [7] Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Leo, Giovanni
    Pampaloni, Francesca
    Messina, Francesco
    Doria, Andrea
    Piaserico, Stefano
    Ramonda, Roberta
    [J]. DERMATOLOGY, 2022, 238 (05) : 897 - 903
  • [8] Prevalence of psoriasis and psoriatic arthritis in Germany - analysis of claims data
    Hagenstroem, Kristina
    Mueller, Katharina
    Garbe, Claudia
    Augustin, Matthias
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (01): : 55 - 55
  • [9] Prevalence of psoriasis and psoriatic arthritis in Germany - analysis of claims data
    Hagenstroem, Kristina
    Mueller, Katharina
    Garbe, Claudia
    Augustin, Matthias
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 (01): : 45 - 55
  • [10] A Comparison of Quality of Life Outcomes Between Psoriatic Arthritis and Psoriasis Patients: Data from the Brigham Cohort for Psoriasis and Psoriatic Arthritis Registry (COPPAR)
    Shadick, Nancy
    Schnock, Kumiko
    Feather, Vivi
    Cui, Jing
    Maica, Gabriela
    Marshall, Alexa
    Francis, Wynona
    Yussuff, Muibat
    Chada, Lourdes Maria Perez
    Weinblatt, Michael E.
    Merola, Joseph
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3706 - 3709